Cognition Therapeutics Inc Earnings

The next earnings date for Cognition Therapeutics Inc is November 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Cognition Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/12/2025	$-0.10

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Cognition Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	---	$-0.11	-4.76%
06/06/2025	Before Market	$-0.14	44.00%
11/13/2024	---	$-0.25	-17.21%
08/08/2024	Before Market	$-0.18	21.74%
05/07/2024	Before Market	$-0.27	-8.00%
03/26/2024	Before Market	$-0.27	20.59%
11/02/2023	Before Market	$-0.22	8.33%
08/08/2023	Before Market	$-0.16	15.79%
05/04/2023	After Market	$-0.21	-16.67%
03/23/2023	Before Market	$-0.20	9.09%
11/14/2022	Before Market	$-0.29	23.68%
08/09/2022	Before Market	$-0.25	21.88%
05/11/2022	Before Market	$-0.17	41.38%
03/30/2022	Before Market	$-11.74	-4,415.38%
11/17/2021	After Market	$-8.12	-1,324.56%
07/19/2021	---	$-0.17	---
06/30/2021	---	$-4.77	---
03/31/2021	---	$-1.64	---
06/30/2020	---	$-5.59	---
03/31/2020	---	$-7.58	---

More About Cognition Therapeutics Inc

Website

https://www.cogrx.com

Country

USA

Full Time Employees

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.

“Cognition Therapeutics Inc Earnings” Can Refer to the Cognition Therapeutics Inc Earnings Date

Some people say “Cognition Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Cognition Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Cognition Therapeutics Inc Stock on the Earnings Date

If you own Cognition Therapeutics Inc stock (CGTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Cognition Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Cognition Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Cognition Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Cognition Therapeutics Inc earnings or anything else related to the stock market.